CN117398442A - 一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂 - Google Patents
一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂 Download PDFInfo
- Publication number
- CN117398442A CN117398442A CN202311498587.9A CN202311498587A CN117398442A CN 117398442 A CN117398442 A CN 117398442A CN 202311498587 A CN202311498587 A CN 202311498587A CN 117398442 A CN117398442 A CN 117398442A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- fine powder
- skin mucosa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 210000004877 mucosa Anatomy 0.000 title claims abstract description 19
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 23
- 230000008439 repair process Effects 0.000 title claims description 5
- 239000003814 drug Substances 0.000 claims abstract description 80
- 241001164374 Calyx Species 0.000 claims abstract description 17
- 244000064622 Physalis edulis Species 0.000 claims abstract description 17
- 241000304531 Allium macrostemon Species 0.000 claims abstract description 13
- 240000008537 Burchellia bubalina Species 0.000 claims abstract description 13
- 235000004415 Burchellia bubalina Nutrition 0.000 claims abstract description 13
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 11
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 10
- 241000915604 Scutellaria barbata Species 0.000 claims abstract description 10
- 240000000249 Morus alba Species 0.000 claims abstract description 9
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 9
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 9
- 244000197580 Poria cocos Species 0.000 claims abstract description 9
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 9
- 230000003115 biocidal effect Effects 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 14
- 240000002853 Nelumbo nucifera Species 0.000 claims description 13
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 13
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 claims description 11
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 claims description 11
- 241000723353 Chrysanthemum Species 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 241001313857 Bletilla striata Species 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 42
- 230000000694 effects Effects 0.000 abstract description 25
- 229940079593 drug Drugs 0.000 abstract description 23
- 208000024891 symptom Diseases 0.000 abstract description 7
- 238000011160 research Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 210000000936 intestine Anatomy 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000244987 Daiswa polyphylla Species 0.000 abstract 1
- 241001145025 Saussurea involucrata Species 0.000 abstract 1
- 230000003628 erosive effect Effects 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 206010052428 Wound Diseases 0.000 description 7
- 239000000645 desinfectant Substances 0.000 description 6
- 206010008342 Cervix carcinoma Diseases 0.000 description 5
- 206010053615 Thermal burn Diseases 0.000 description 5
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 5
- 201000010881 cervical cancer Diseases 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241001313855 Bletilla Species 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000008960 Diabetic foot Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000012744 reinforcing agent Substances 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 208000004483 Dyspareunia Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 241000341655 Human papillomavirus type 16 Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241000358374 Mupapillomavirus 1 Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000010442 acute cervicitis Diseases 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 230000004956 cell adhesive effect Effects 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000010409 ironing Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 210000000811 metacarpophalangeal joint Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960002566 papillomavirus vaccine Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
Abstract
本发明提供一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂,用于治疗皮肤和粘膜感染,由雪莲花、水牛角、薤白、茯苓、芦根、白癣皮、蚤休、菊花、半枝莲、锦灯笼、桑白皮、金银花等药物,根据传统中医理论,结合现代医药研究成果和中医临床经验研制而成。所选药物为纯中草药,协同配伍合理,外部给药,药物直接作用患处,药物作用迅速,免除口服制剂对胃肠肝肾的刺激,减少患者痛苦,疗程短、费用低,使用方便,临床症状消失迅速,疗效显著,实用方便安全,无毒副作用。
Description
技术领域
本发明提供一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂,用于治疗皮肤和粘膜感染,同时还提供了该中药制剂的制备方法,属于中药制药技术领域。
背景技术
日常生活中为了卫生安全,人们通常使用消毒液类的对周边环境或人体进行喷洒消毒杀菌,由于大多数消毒制剂特别是“84消毒液”毒副作用特别大,喷洒消毒液过程中,虽然可以杀灭病毒病菌,但是也会因防护不慎,导致消毒液对人体的皮肤或呼吸道的粘膜系统造成损害;因此,提供一种即能广谱抗病菌的同时还能快速的修复细胞粘糊膜组织制剂是本发明的主要任务。
发明内容
本发明公开一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂及制备方法,解决了高效灭菌抗病毒,又能快速修复受损皮肤及和粘膜的问题,真正做到了扶正驱邪、灭菌抗病毒的目的,为人体建立起第一道屏障。
本发明提供了一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂,是由如下原料按重量份数比制成的:
雪莲花2-20份,水牛角3-30份,锦灯笼3-30份,芦根3-30份,薤白3-30份,金银花3-30份,菊花3-30份,蚤休3-30份,半枝莲3-30份,白芨3-30份,茯苓3-30份,桑白皮3-30份。
优选为:雪莲花2-5份, 水牛角3-15份, 锦灯笼3-15份, 芦根3-15份, 薤白3-15份,金银花3-15份,菊花3-15份,蚤休3-15份,半枝莲3-15份,白芨3-15份,茯苓3-15份,桑白皮3-15份。
最优选为:雪莲花2份、水牛角3份、锦灯笼3份、芦根3份、薤白3份、金银花3份、菊花3份、蚤休3份、半枝莲3份、白芨3份、茯苓3份、桑白皮3份。
本发明原料得到的活性成份,可加入微量的二癸基二甲基氯化铵,制成的抗菌液,能成倍提高抗菌和黏膜修复效果。
本发明提供一种高效广谱抗菌、修复黏膜细胞抗菌液的制备方法,包括如下步骤:
(1)按比例称取雪莲花、水牛角、薤白、 茯苓、芦根、白癣皮、蚤休、菊花、半枝莲、锦灯笼、桑白皮 、金银花。
(2)二氧化碳超低温临界淬取法分别淬取以上12味
(3)将淬取的药粉加入药用蒸馏水,再加入增强剂二癸基二甲基氯化铵,即制成高效广谱皮肤抗菌黏膜修复液。
本发明所说的制备方法,其优选方案为:
(1)按比例取(以上12味中药雪莲花、水牛角、薤白、 茯苓、芦根、白癣皮、蚤休、菊花、 半枝莲、锦灯笼、桑白皮 、金银花)煎煮3次,每次2h合并药液得稠膏。
(2)将稠膏减压干燥(0.08mpa 70-85℃)粉碎成细粉备用
(3)将所得细粉为细粉重量1000-5000%的药用蒸馏水混合制成液体即得。
本发明所说的制备方法,其最优选方案为:
(1)按比例称取雪莲花100g、水牛角300g (其余10味都是300g)加8倍水煎煮3次,次/2h,滤过合并滤液浓缩至稠膏(相对密度1.45-1.50.60℃次日)。
(2)将稠膏减压干燥粉碎成细粉
(3)将所得细粉与细粉重量1000-5000%的药用蒸馏水混合加入0.02%的二癸基二甲基氯化铵,制成3300.000mL(3300kg)的抗菌液,即得高效广谱用于皮肤和皮肤黏膜的抗菌液。
[用法用量]3-5次/日 0.5-1mL/次。
[适应症]具有高效广谱抗菌(抗病毒)快速修复黏膜的作用。
本发明的药理药效方解如下:君药:本发明君药是雪莲花、水牛角;雪莲花现代研究发现其在美容养颜尤其在抗氧化抗衰老方面作用明显并且能提高机体整体代谢功能,但在抗菌消炎方面略显不足。臣药:取了锦灯笼、芦根、蚤休、金银花做为臣药。金银花是众所周知的抗菌消炎药。而锦灯笼也是在皮肤抗菌液中首次使用,锦灯笼在抗菌消炎中,尤其是在治疗急性咽炎、慢性咽炎效果独特,其在皮肤抗菌液中使用,有作用范围广、不产生任何副作用的特点。蚤休是一味具有强力抗菌消炎的中药,芦根根据中医理论:具有滋阴清虚热解毒的作用。本发明4种药是强力的组合.配伍金银花后疗效更为显著;佐药:薤白、半枝莲、菊花、白芨以上4味佐药是为了治疗兼证或者是为了使主药、辅药更好地发挥药力,创造有利条件给主药辅药增强效力。薤白通常认为具有温通心阳的作用,本发明用于由于阻塞凝滞、胸阳不振、引起的各种皮肤感染,且具有加快伤口创面皮肤愈合的作用;使药:白芨、茯苓、桑白皮、白芨、和桑白皮能引导药力直达病位(皮肤)使主药和辅药更好地发挥药力而创造有利条件.桑白皮能以皮(树皮)治皮(肤)是中医比类取相法的具体体现和应用。
本发明组方剂配伍将水牛角、锦灯笼、薤白用于皮肤抗菌起到意想不到的治疗效果。用极微量的二癸基二甲基氯化铵(0.01-0.03%)做为12味中药的增强剂,就能使皮肤抗菌液中的微量中药成份的药效得到成倍的提高(需要通过对比数据)。
本发明对以下的疾病具有明显的疗效:
皮肤病:1.褥疮2.带状疱疹3.糖尿病足4.烧烫伤(Ⅱ度以下烧烫伤不用去无菌病房,第一时间使用不留疤痕)5.严重的久治不愈口腔溃疡6.久治不愈合的伤口和瘘。
妇科:1.盆腔炎2.Ⅲ度宫颈糜烂(以上二种病1个月内治愈率为87.5%以上)3.HPV宫颈癌高危型阳性(3个月内转阴率在85%)。
本发明配方组合中:锦灯笼、水牛角、薤白等三种中药是首次在中医皮肤科和中医妇科中使用。本发明配方中选用二癸基二甲基氯化铵和其它药物组合配伍,产生了新的药效和功效,很多中西药临床上难以治愈的疾病都能得到治愈;传统上二癸基二甲基氯化铵做皮肤消毒剂用量是0.3%,本发明提供了其最佳浓度配比和中药组合;二癸基二甲基氯化铵的浓度在0.02%以下,中药的总含量在0.01%,药效和功效明显,很多中西药临床上难以治愈的疾病都能得到治愈。治愈率在90%以上。例如裖疮、带状疱疹、烧烫伤(Ⅱ度以内的烧烫伤不用进无菌室病房)治愈,在普通病房第一时间用上该药品就能治愈,且不留疤痕,更重要的是烧伤创面处能长出汗毛,而其它治法疗即便治愈烧烫伤处也是要落疤痕的,且不长毛孔(该处皮肤不能呼吸)。糖尿病足亦如此。
用本发明药物治疗妇科的盆腔炎,Ⅲ度宫颈糜烂一般在一个月内即可治愈;HPV宫颈癌高危人群转阴。现在市售的进口HPV疫苗是9价。而高危人群 HPV宫颈癌高危型是17种亚型即17+。本发明的药物是广谱抗HPV宫颈癌高危型,对所有的宫颈癌高危型都有效,使用该药品在3个月内转阴率可高达85%。
本发明的积极效果在于:
根据传统中医理论,结合现代医药研究成果和中医临床经验研制而成。所选药物为纯中草药,协同配伍合理,外部给药,药物直接作用患处,药物作用迅速,免除口服制剂对胃肠肝肾的刺激,减少患者痛苦,疗程短、费用低,使用方便,临床症状消失迅速,疗效显著,实用方便安全,无毒副作用。
附图说明
图1为本发明病例1治疗前后效果照片;
图2为本发明病例2治疗前后效果照片;
图3为本发明病例3治疗前后效果照片;
图4为本发明病例4治疗前后效果照片;
图5.图6为本发明病例5治疗前后效果照片。
具体实施方式
通过以下实施例进一步举例描述本发明,并不以任何方式限制本发明,在不背离本发明的技术解决方案的前提下,对本发明所作的本领域普通技术人员容易实现的任何改动或改变都将落入本发明的权利要求范围之内。
实施例1
(1)按比例称取雪莲花100g、水牛角100g、锦灯笼150g、芦根150g、薤白150g、金银花150g、菊花150g、蚤休150g、半枝莲150g、白芨150g、茯苓150g 、桑白皮150g;
(2)二氧化碳超低温临界淬取法分别淬取以上12味原料;
(3)将步骤2)淬取的药粉加入药用蒸馏水,再加入增强剂二癸基二甲基氯化铵0.02%即得。
实施例2
(1)按比例取:雪莲花200g、水牛角300g、锦灯笼300g、芦根300g、薤白300g、金银花300g、菊花300g、蚤休300g、半枝莲300g、白芨300g、茯苓300g 、桑白皮300g,煎煮3次,每次2h合并药液得稠膏;
(2)将稠膏0.08mpa 70-85℃减压干燥粉碎成细粉;
(3)将步骤2)所得细粉为细粉重量1000-5000%的药用蒸馏水混合制得。
实施例3
(1)按比例称取雪莲花100g、水牛角300g,其余10味称取300g,加8倍水煎煮3次,次/2h,滤过合并滤液浓缩至稠膏,相对密度1.45-1.50.60℃次日;
(2)将稠膏减压干燥粉碎成细粉;
(3)将步骤2)所得细粉与细粉重量1000-5000%的药用蒸馏水混合加入0.02%的二癸基二甲基氯化铵,制成3300.000mL(3300kg)的抗菌液。
下面结合临床进一步说明本发明的积极效果:
中药治疗宫颈糜烂80例临床疗效观察
1 临床资料
1.1 研究对象:选取自2018年5月至2020年8月在本发明研究院和门诊部联合开展的妇科临床治疗研究接受治疗的宫颈糜烂面积较大患者80例,患者全部有过生育,年龄在25岁到50岁间;80例患者中,治疗组40例经中药治疗,对照组40例采用常规治疗。两组诊断标准及疗效标准均一致。80例中,74例为门诊病人,26例为住院病人。年龄在25~50岁之间,其中35岁以下 6例,35~40岁44例,40~45岁23例,45岁以上7例;病程2~3年者53例,4~6年者16例,7 ~10年者8例,10年以上者3例;2组患者在年龄、病程等方面差异无显著性,具有可比性。80例患者均愿意接受中药治疗者。
1.2 诊断标准 宫颈糜烂的主要临床表现以白带增多为主。由于病原菌的不同,所产生的白带的色泽也是不一样的,有的呈乳白色黏液样,有的呈淡黄色或脓性或血性白带,以乳白色黏液样白带最常见;除白带增多外,患者可能伴有腰部酸痛,性交出血。其病因大多是由于性生活或分娩时损伤宫颈,从而导致细菌侵入而得产生,当然也有因自身体质虚弱,经期细菌感染所造成。目前妇科检查为宫颈糜烂确诊的主要手段。一般分为3型:①单纯型:糜烂表面的柱状上皮,生长平坦、光滑。症状较轻;②乳头状:间质增生异常显著,表面更加不平而呈乳头状;症状明显;③颗粒型:腺上皮过度增生,伴间质增生,使表面凹凸不平,呈颗粒状。治愈后症状减缓可至消失。
2 方法
2.1 治疗方法:(1)对照组40例采用物理常规治疗,采用医用电熨器,将糜烂面组织烧灼使之坏死脱落;(2)治疗组采用我们研制的高效广谱和快速修复皮肤粘膜的妇科型中药制剂外用,每次5ml阴道给药,每用药5天休息2天,一个月一疗程,一个月18支药,如遇经期停用。治法:清热解毒,利湿。
2.2 统计学方法 本研究以χ2 检验进行统计学处理。
3 结果
(1)对照组治愈率为0例(0%),显效16例(40%),有效15例(38%),无效9例(22%)。
(2)治疗组治愈35例(87.5%),显效3例(7.5%),无效2例(5%)。而我们的中药制剂治疗宫颈糜烂治愈率高。
表1 治疗组与对照组治愈率比较
注:经χ2 检验治疗组治愈率和显效率明显优于对照组,差异有显著性。
结论:
宫颈糜烂是一种常见的妇科疾病,多由急性宫颈炎治疗不彻底转变而来,病程有的可长达数十年,经药物长期治疗,大多数宫颈糜烂患者经输液服药等不见好转,效果不佳,这严重影响了患者的身心健康、工作及生活。
病例1
某男,56岁,2022年11月去医院就诊,手背第一掌指关节处有一3CM*3CM左右的痛风石结节,手术摘除后的3个月没有封口且伤口疼痛,打消炎针无效;
治疗:用本发明的药液,喷涂创面每日3-4次,0.5mL/次,使用一周创面开始缩小,约一个月左右痊愈(参见图1)。
病例2
某童 1.5岁,某年某月份发现大腿腹股沟处有成遍的红色的幼儿湿疹,均有2mm厚度,幼儿哭闹不宁,经用肤肌宁药膏等治疗无效;
治疗:用本发明的药液喷涂患处当天见效,3天即有明显的好转,6天痊愈。数月后又发现腿部足部有红疹,经医院儿科检查诊断为手足口病(不典型),医院建议用消炎药治疗,家长没采纳。没用任何其它药物治疗,用本发明的抗菌药液治疗,每日喷涂患处4-5次(每次约1ml),治疗十天左右痊愈(参见图2)。
病例3
某男,65岁患糖尿病8年,每天注射胰岛素50个单位,餐前血糖仍在16左右。于某年初双小腿皮肤变黑,尤以左腿小腿外侧为重并开始溃烂,在某三甲医院内分泌科用其它中西药治疗无效且有加重趋势;
治疗:用本发明的药液每日喷涂小腿患处4-5次,每次1-2mL,约一周左右溃皮溃烂处开始好转,继续使用本发明的药物一个月左右,皮肤溃烂处明显好转.使用本发明的药物治疗2个月左右,皮肤溃烂处结痂康复(参见图3)。
病例4
某男67岁,医院诊断为过敏性皮炎。有长期接触化工原料史。近15年来小腿部皮炎加重,瘙痒难忍且皮下有多发性节结。经多方医治无效;
治疗:用本抗菌液治疗,每次1mL每日3-4次,经一个月治疗后,不再瘙痒且皮下结节消失(参见图4)。
病例5
某男61岁,患糖尿病数十年,视物模糊,出现糖尿病眼底病变。一次用热水洗脚,因足部对温度不敏感而导致烫伤后出现足底溃烂久不愈合;
治疗:用本抗菌液治疗1.5mI/次4次/日,经3个月左右的治疗溃烂处愈合(参见图5,图6)。
病例6
某女59岁 ,婚后生子后经常腰痛白带增多有时还有异味,经医院妇科诊断B超等检查,诊断为盆腔炎并伴有盆腔积液(约15mL左右)经多方治疗无效;
治疗:用本发明的药液用妇科给药器经阴道给药5mL/次,用药3天休二天然后再给药,每个月18支药,一个月一个疗程。用药一个月后,经阴道排出大量的污物,经过持续3个月的治疗,腰痛症状消失白带恢复正常,经B超检查盆腔积液消失。
病例7
某女31岁,痛经,白带异常,经查宫颈2度糜烂,HPV16、18阳性,医院建议做锥切,本人不同意治疗。用本发明的抗菌剂妇科型治疗,每日一次,5mL/次,用3天休2天,每月治疗18次,治疗一个月后做妇科检查,宫颈恢复正常,痛经已明显减轻,继续按原方案治疗,一个月后HPV转阴。
病例8
某女,54岁,人乳头瘤病毒1.有HPV[27]分型 HPV-DNA检测:HPV-DNA-59型为阳性。2.妇科检查宫颈欠光滑。在医院用干扰素300万单位注射,妇科外用药医治一年无效。
治疗:用本发明的药液用妇科给药器经阴道给药5mI/次,用药3天休2天,然后再给药,每个月18支药,3个月一个疗程,用本药期间不再用其它任何药物,用药3个月后休息半个月去复查HPV阳性全部转阴。
Claims (6)
1.一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂,其特征在于是由以下原料按重量份数比制成的:
雪莲花2-20份,水牛角3-30份,锦灯笼3-30份,芦根3-30份,薤白3-30份,金银花3-30份,菊花3-30份,蚤休3-30份,半枝莲3-30份,白芨3-30份,茯苓3-30份,桑白皮3-30份。
2.如权利要求1所说的一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂,其特征在于优选为:
雪莲花2-5份, 水牛角3-15份, 锦灯笼3-15份, 芦根3-15份, 薤白3-15份,金银花3-15份,菊花3-15份,蚤休3-15份,半枝莲3-15份,白芨3-15份,茯苓3-15份,桑白皮3-15份。
3.如权利要求1所说的一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂,其特征在于最优选为:
雪莲花2份、水牛角3份、锦灯笼3份、芦根3份、薤白3份、金银花3份、菊花3份、蚤休3份、半枝莲3份、白芨3份、茯苓3份、桑白皮3份。
4.如权利要求1~3所说的一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂的制备方法,其特征在于包括以下步骤:
(1)按比例称取雪莲花、水牛角、薤白、茯苓、芦根、白癣皮、蚤休、菊花、半枝莲、锦灯笼、桑白皮、金银花;
(2)二氧化碳超低温临界淬取法分别淬取以上12味原料;
(3)将步骤2)淬取的药粉加入药用蒸馏水,再加入0.02%的增强剂二癸基二甲基氯化铵,即得。
5.如权利要求1~3所说的一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂的制备方法,其特征在于包括以下步骤:
(1)按比例取雪莲花、水牛角、薤白、 茯苓、芦根、白癣皮、蚤休、菊花、 半枝莲、锦灯笼、桑白皮 、金银花,煎煮3次,每次2h合并药液得稠膏;
(2)将稠膏0.08mpa 70-85℃减压干燥粉碎成细粉;
(3)将步骤2)所得细粉为细粉重量1000-5000%的药用蒸馏水混合制得。
6.如权利要求1~3所说的一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂的制备方法,其特征在于包括以下步骤:
(1)按比例称取雪莲花100g、水牛角300g ,其余10味称取300g,加8倍水煎煮3次,次/2h,滤过合并滤液浓缩至稠膏,相对密度1.45-1.50.60℃次日;
(2)将稠膏减压干燥粉碎成细粉;
(3)将步骤2)所得细粉与细粉重量1000-5000%的药用蒸馏水混合加入0.02%的二癸基二甲基氯化铵,制成3300.000mL(3300kg)的抗菌液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311498587.9A CN117398442A (zh) | 2023-11-12 | 2023-11-12 | 一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311498587.9A CN117398442A (zh) | 2023-11-12 | 2023-11-12 | 一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117398442A true CN117398442A (zh) | 2024-01-16 |
Family
ID=89488952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311498587.9A Pending CN117398442A (zh) | 2023-11-12 | 2023-11-12 | 一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117398442A (zh) |
-
2023
- 2023-11-12 CN CN202311498587.9A patent/CN117398442A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100563690C (zh) | 一种治疗风湿、类风湿、产后风、骨质增生和腰间盘突出疾病的药物 | |
CN103652501B (zh) | 用于治疗奶牛乳房炎的饲料及其制备方法 | |
CN103463539A (zh) | 一种治疗湿疹的药物及其制备方法和用途 | |
CN105943666B (zh) | 一种用于婴幼儿敏感肌肤护理的组合物及其制备方法 | |
CN103638316B (zh) | 一种治疗皮炎的中药制剂 | |
CN104706953A (zh) | 一种治疗慢性子宫颈炎的中药制剂 | |
CN105250712B (zh) | 一种治疗褥疮的中药组合物 | |
CN117398442A (zh) | 一种高效广谱抗菌和快速修复皮肤粘膜的中药制剂 | |
CN100540030C (zh) | 一种治疗妇女痛经的外敷药剂 | |
CN106806545A (zh) | 一种化腐生肌中草药组合物及其制备方法 | |
CN110585379A (zh) | 一种皮炎治疗外敷药物 | |
CN103768290A (zh) | 一种治疗滑膜炎的中药组合物及其制备方法 | |
CN109925426A (zh) | 一种可以治疗痔疮的中药熏蒸剂 | |
CN115429859B (zh) | 治疗皮肤瘙痒性疾病的中药组合物及其制备方法、用途 | |
CN107334941A (zh) | 一种治疗慢性盆腔炎的中药及其制备方法 | |
CN107335034A (zh) | 一种治疗白癜风的外用中药组合物及其应用 | |
US20240091190A1 (en) | Skin cream for reducing bed sores | |
CN102228661B (zh) | 一种治疗慢性胆囊炎的中药合剂 | |
CN107080817A (zh) | 一种新型妇科千金莪术油栓 | |
CN100352469C (zh) | 一种治疗烧烫伤的外用药物 | |
CN105832965A (zh) | 治疗烧烫伤的中药制剂及其制备方法 | |
CN106038913B (zh) | 一种治疗妇科宫颈炎的中药组合物及其应用 | |
CN105726789A (zh) | 一种用于治疗褥疮的护理药物制剂及其用途 | |
CN105920455B (zh) | 一种治疗疣病的中药制剂 | |
CN105265786A (zh) | 一种牛配合饲料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |